Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.
J Microbiol Methods
; 90(2): 83-5, 2012 Aug.
Article
en En
| MEDLINE
| ID: mdl-22565213
ABSTRACT
Three commercial molecular assays were evaluated for toxigenic Clostridium difficile detection in stools. As compared to toxigenic culture, BD GeneOhm Cdiff (BD Diagnostics), XPert C. difficile (Cepheid) and illumigene C. difficile (Meridian Bioscience) demonstrated respectively a sensitivity of 95.5%, 97.8% and 86.7% and a specificity of 97.9%, 97.9% and 100%.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Toxinas Bacterianas
/
Clostridioides difficile
/
Técnicas Bacteriológicas
/
Infecciones por Clostridium
/
Técnicas de Diagnóstico Molecular
/
Heces
Tipo de estudio:
Diagnostic_studies
/
Evaluation_studies
Límite:
Humans
Idioma:
En
Revista:
J Microbiol Methods
Año:
2012
Tipo del documento:
Article
País de afiliación:
Francia